Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Vaccine Stocks Checkup: Johnson & Johnson Is Rising
By Alicia Stein
Apr 20, 2021 2:49 PM EDT
PRESS RELEASES
Kazia Licenses Global Rights To EVT801, A Novel, First-in-Class, Clinic-Ready, VEGFR3 Inhibitor, From Evotec SE
By PR Newswire
Apr 19, 2021 5:36 AM EDT
INVESTING
Vaccine Stocks Checkup: Johnson & Johnson COVID-19 Vaccine Paused
By Alicia Stein
Apr 13, 2021 9:35 AM EDT
INVESTING
Vaccine Stocks Checkup: Johnson & Johnson, Pfizer Update
By Alicia Stein
Apr 5, 2021 9:37 AM EDT
JIM CRAMER
Market Recap With Jim Cramer: Stocks to Buy Now
By Danny Peterson
Mar 22, 2021 8:00 AM EDT
INVESTING
Vaccine Stocks Checkup: Novavax Surges Friday
By Danny Peterson
Mar 20, 2021 9:30 AM EDT
INVESTING
Translate Bio Tumbles on Cystic Fibrosis Drug Study Results
By Rob Lenihan
Mar 18, 2021 11:25 AM EDT
INVESTING
Translate Bio, Sanofi Begin Trials of COVID Vaccine Candidate
By Fionna Agomuoh
Mar 12, 2021 10:29 AM EST
INVESTING
GlaxoSmithKline and Sanofi Re-Start COVID Vaccine Trials
By Martin Baccardax
Feb 22, 2021 6:52 AM EST
JIM CRAMER
Game Plan: Cramer's 'Mad Money' Recap (Friday 2/5/21)
By Scott Rutt
Feb 5, 2021 7:48 PM EST
Video
Sanofi Turns to Rival BioNTech to Crank Out More Covid-19 Vaccines
Jan 27, 2021 9:54 AM EST
INVESTING
Pfizer and BioNTech Get Help From Sanofi on Vaccine Production
By M. Corey Goldman
Jan 27, 2021 6:35 AM EST
PRESS RELEASES
Biond Biologics And Sanofi Enter Into Global Licensing Agreement For BND-22, A Novel Immune Checkpoint Inhibitor Targeting The ILT2 Receptor
By PR Newswire
Jan 12, 2021 8:00 AM EST
INVESTING
TG Therapeutics Soars on Positive Results for MS Treatment
By Rob Lenihan
Dec 10, 2020 2:24 PM EST
PRESS RELEASES
Canadians Living With Multiple Sclerosis Find Support During COVID-19 Pandemic Through Dedicated Social Media Network
By PR Newswire
Dec 8, 2020 10:00 AM EST
Video
EU and U.S. Working With Moderna and BioNTech on Vaccine Rollout
Nov 20, 2020 10:05 AM EST
INVESTING
Moderna and BioNTech Looking at Imminent EU Vaccine Approval
By M. Corey Goldman
Nov 20, 2020 10:06 AM EST
INVESTING
Regeneron Posts Better-Than-Expected Third-Quarter Earnings
By M. Corey Goldman
Nov 5, 2020 9:42 AM EST
JIM CRAMER
Small Biz Needs Help: Cramer's 'Mad Money' Recap (Thursday 9/24/20)
By Bret Kenwell
Sep 24, 2020 8:43 PM EDT
PRESS RELEASES
(PRNB) Alert: Johnson Fistel Investigates Proposed Sale Of Principia Biopharma; Is $100 A Fair Price?
By PR Newswire
Sep 12, 2020 8:40 AM EDT
INVESTING
AstraZeneca Shares Fall After COVID-19 Vaccine Study Placed on Hold
By Tom Bemis
Sep 8, 2020 7:05 PM EDT
PRESS RELEASES
Biopharma Leaders Unite To Stand With Science
By GlobeNewswire
Sep 8, 2020 6:30 AM EDT
Video
Coronavirus Update: Vaccine News From Sanofi and Novovax
Sep 3, 2020 8:47 AM EDT
INVESTING
Novavax Gains Following Promising Covid-19 Vaccine Trials
By M. Corey Goldman
Sep 3, 2020 9:35 AM EDT
INVESTING
Sanofi Fast-Tracking Covid-19 Vaccine to Human Trials
By M. Corey Goldman
Sep 3, 2020 9:37 AM EDT
